Latest Breaking News On - Developmental endocrinology branch - Page 1 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth . Lumos Pharma, Inc.April 14, 2021 GMT AUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ: LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that it will host a key opinion leader (KOL) webinar on LUM-201 on Tuesday, April 27, 2021, at 10:30am ET. LUM-201 is the Company’s orally administered therapeutic candidate for the treatment of pediatric growth hormone deficiency (PGHD). The event will feature presentations by KOLs in the field of pediatric endocrinology, Bradley S. Miller, M.D., Ph.D., University of Minnesota, and Fernando Cassorla, M.D., University of Chile, who will discuss the currently available treatments and unmet medical needs in PGHD. Drs. Miller and Cassorla will be available to answer questi

DeerfieldNew yorkUnited statesChileTexasAlbany medical centerPhiladelphiaPennsylvaniaNew enterpriseChileanFernando cassorlaCorey davisBradleys millerLisa millerLumos pharmaChilean academy of medicine